Skip to main content
SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.530
+0.060 (1.73%)
At close: Apr 28, 2026, 4:00 PM EDT
3.500
-0.030 (-0.85%)
After-hours: Apr 28, 2026, 6:20 PM EDT

SAB Biotherapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
86
Market Cap
248.07M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 20241.32M-916.58K-40.94%
Dec 31, 20232.24M-21.67M-90.63%
Dec 31, 202223.90M-36.97M-60.73%
Dec 31, 202160.88M5.64M10.21%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Arcturus Therapeutics Holdings 82.03M
Codexis 70.39M
Fennec Pharmaceuticals 44.64M
Orchestra BioMed Holdings 33.48M
Sol-Gel Technologies 19.39M
Adagene 7.67M
Camp4 Therapeutics 3.50M
Milestone Pharmaceuticals 1.55M
Revenue Rankings

SABS News

More News